NeuroTalk Support Groups - NP001 Fails to Improve Disease Severity, Pulmonary Function in ALS Patients, Phase 2

NeuroTalk Support Groups (https://www.neurotalk.org/)

- ALS News & Research (https://www.neurotalk.org/als-news-and-research/)

- - NP001 Fails to Improve Disease Severity, Pulmonary Function in ALS Patients, Phase 2 (https://www.neurotalk.org/als-news-and-research/251397-np001-fails-improve-disease-severity-pulmonary-function-als-patients-phase-2-a.html)

MuonOne

04-28-2018 05:03 PM

NP001 Fails to Improve Disease Severity, Pulmonary Function in ALS Patients, Phase 2

#AAN2018 — NP001 Fails to Improve Disease Severity, Pulmonary Function in ALS Patients, Phase 2 Trial Shows

#AAN2�18 - NP��1 Fails to Improve ALS Disease Severity in Phase 2 Trial

NP001 probably generated more interest among ALS patients than any product in history.

All times are GMT -5. The time now is 03:20 PM.